A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib
| Title: | A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib |
|---|---|
| Authors: | Moran, Teresa, Palmero, Ramón, Provencio, Mariano, Insa, Amelia, Majem, Margarita, Reguart, Noemí, Bosch-Barrera, Joaquim, Isla, Dolores, Costa, Enric Carcereny, Lee, Chooi, Puig, Marta, Kraemer, Sandrine, Schnell, David, Rosell, Rafael |
| Source: | In Lung Cancer June 2017 108:154-160 |
| Database: | ScienceDirect |
Be the first to leave a comment!